While Spravato’s underlying mechanisms remain ... some critics continue to voice concerns about lingering long-term health questions and unregulated clinics. Licensed medical providers have ...

Spravato isn’t like the nasal spray you use ... More research is needed to answer those questions. Clinical trials are underway or being planned to test esketamine in postpartum depression ...

My two questions. First of all ... positive commentary on some of the newer drugs you've had, whether that's Spravato broadening or neffy coming out of the gate in 4Q, would you say that 2025 ...

Spravato (esketamine ... In draft guidance, NICE says that there are questions about not only the price of the medicine – which costs around £10,500 per course of therapy ahead of any discounts ...

With SPRAVATO surpassing $1 billion in annual sales ... With that, we are happy to take your questions. So I will now turn it to Kevin to provide instructions for those seeking to participate ...

Q4 2024 Earnings Call Transcript February 7, 2025 Operator: Ladies and gentlemen, thank you for standing by. Welcome to ...

"SPRAVATO ® is now available as a standalone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days – without the need for daily oral ...

Johnson & Johnson JNJ announced that the FDA has approved its supplemental new drug application (sNDA), seeking approval for Spravato (esketamine) as a monotherapy for adults living with treatment ...

Spravato is classified as a Schedule III controlled substance and is only available through a restricted program called the Spravato REMS. The Food and Drug Administration (FDA) has approved ...

Credit: Johnson & Johnson. The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, placebo-controlled, phase 4 TRD4005 trial.

Spravato, okayed for stand-alone use among adults, is the first such therapy for major depressive disorder (MDD) that is difficult to treat. The United States Food and Drug Administration (FDA ...